[email protected] +91 9789129171
ICCBMO · Registering as Listener

International Conference on Cancer Biology and Molecular Oncology

21 - 22 Dec 2026 Abu Dhabi, UAE Standard / Physical Participation
Listener Registration
$115
virtual · $175 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICCBMO
ModeStandard / Physical
ParticipationListener
Registration fee$175.00
Bank charges (5.8%)$10.15
Total payable$185.15
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICCBMO conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 11 - Sustainable Cities and Communities
01 Molecular Mechanisms of Tumorigenesis +
This session will explore the intricate molecular pathways involved in tumorigenesis, focusing on the roles of oncogenes and tumor suppressor genes. Discussions will include recent advancements in understanding the genetic and epigenetic alterations that drive cancer development.
02 Cancer Signaling Pathways +
This track will delve into the complex signaling networks that regulate cell proliferation and apoptosis in cancer. Participants will examine how dysregulation of these pathways contributes to tumor growth and metastasis.
03 Targeted Therapies in Oncology +
This session will highlight the latest innovations in targeted therapies aimed at specific molecular targets in cancer cells. Emphasis will be placed on the mechanisms of action, efficacy, and resistance associated with these therapeutic approaches.
04 Cancer Genomics and Epigenetics +
This track will focus on the integration of genomic and epigenetic data to understand cancer biology. Researchers will present findings on how these layers of regulation influence tumor behavior and patient outcomes.
05 Tumor Microenvironment and Angiogenesis +
This session will investigate the interactions between tumor cells and their microenvironment, with a particular focus on angiogenesis. Discussions will include how these interactions facilitate cancer progression and therapeutic resistance.
06 Cancer Stem Cells and Metastasis +
This track will explore the role of cancer stem cells in tumor initiation and metastasis. Researchers will discuss the unique properties of these cells and their implications for treatment strategies.
07 Molecular Diagnostics in Cancer +
This session will cover the advancements in molecular diagnostics that enhance cancer detection and monitoring. Topics will include the development of biomarkers and their clinical applications in personalized medicine.
08 Chemotherapy Resistance Mechanisms +
This track will examine the biological mechanisms underlying chemotherapy resistance in cancer treatment. Researchers will present novel strategies to overcome resistance and improve therapeutic efficacy.
09 Cancer Immunology and Therapeutics +
This session will focus on the immune system's role in cancer biology and the development of immunotherapeutic strategies. Topics will include immune checkpoint inhibitors, CAR T-cell therapy, and the tumor immune microenvironment.
10 Biomarker Discovery and Clinical Applications +
This track will highlight the latest research in biomarker discovery for cancer diagnosis and prognosis. Emphasis will be placed on translating these findings into clinical practice to improve patient outcomes.
11 Cancer Progression and Therapeutic Strategies +
This session will explore the dynamic processes of cancer progression and the development of innovative therapeutic strategies. Discussions will include the integration of multi-omics approaches to understand and combat cancer.